The case of Synthroid (A) : marketing a drug coming off patent / Alice M. Tybout, Julie Hennessy, Natalie Fahey & Charlotte Snyder.
The case tells the story of Synthroid from its development in 1958 as the first synthetic thyroxine molecule to its competition against generic equivalents in 2004. The case introduces students to the pharmaceutical industry, its practices and some of the complexities of pricing and drug choice, wit...
I tiakina i:
| Ngā kaituhi matua: | , , , |
|---|---|
| Hōputu: | iPukapuka |
| Reo: | English |
| I whakaputaina: |
[London] :
SAGE,
2016.
|
| Rangatū: | SAGE knowledge. Cases.
|
| Ngā marau: | |
| Urunga tuihono: | SAGE |
| Whakarāpopototanga: | The case tells the story of Synthroid from its development in 1958 as the first synthetic thyroxine molecule to its competition against generic equivalents in 2004. The case introduces students to the pharmaceutical industry, its practices and some of the complexities of pricing and drug choice, with drug manufacturers, insurance companies, physicians, pharmacists and patients all playing a role. It also provides a primer on hypothyroidism, its symptoms and its treatment. |
|---|---|
| Whakaahutanga tūemi: | Originally Published in: Tybout, A. M., Hennessy, J., Fahey, N., & Snyder, C. (2013). The Case of Synthroid (A): Marketing a Drug Coming Off Patent (case revised 09/05/2013). 5-312-506(A). Evanston, IL: Kellogg School of Management, Northwestern University. |
| Whakaahuatanga ōkiko: | 1 online resource : illustrations. |
| ISBN: | 1473972205 9781473972209 |